Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -61.84% is 122% below its 5-year average of -27.89%, near the high end of its 5-year range (-235.01%–-10.28%).
As of the fiscal period ended Tuesday, June 30, 2026. 49.59% below its 12-month average of -41.34%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -61.84%.
RETURN ON INVESTED CAPITAL (ROIC)
-61.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-41.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-36.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-27.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-49.59%
CURRENT VS 3Y AVG
-71.14%
CURRENT VS 5Y AVG
-121.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-73.40%
vs the sector median at left
LENZ Therapeutics, Inc.
Market Cap
$118.83M
Return on Invested Capital (ROIC)
-61.84%
TTM Avg
-41.34%
3Y Avg
-36.13%
5Y Avg
-27.89%
Market Cap
$118.59M
Return on Invested Capital (ROIC)
-142.06%
TTM Avg
-89.80%
3Y Avg
-79.42%
5Y Avg
-61.57%
Market Cap
$119.84M
Return on Invested Capital (ROIC)
-17.99%
TTM Avg
-23.22%
3Y Avg
-53.77%
5Y Avg
-63.92%
Market Cap
$117.76M
Return on Invested Capital (ROIC)
-50.67%
TTM Avg
-131.41%
3Y Avg
-97.53%
5Y Avg
-74.13%
Market Cap
$120.41M
Return on Invested Capital (ROIC)
-28.87%
TTM Avg
-28.06%
3Y Avg
-25.36%
5Y Avg
-20.47%
Market Cap
$120.58M
Return on Invested Capital (ROIC)
-1.78%
TTM Avg
-41.34%
3Y Avg
-32.26%
5Y Avg
-28.21%
Market Cap
$116.76M
Return on Invested Capital (ROIC)
-19.83%
TTM Avg
-23.34%
3Y Avg
-19.01%
5Y Avg
-18.39%
Market Cap
$115.67M
Return on Invested Capital (ROIC)
-44.81%
TTM Avg
-53.33%
3Y Avg
-46.90%
5Y Avg
-39.65%
Market Cap
$122.43M
Return on Invested Capital (ROIC)
-3.19%
TTM Avg
-2.23%
3Y Avg
-1.75%
5Y Avg
1.24%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. (LENZ) | $118.83M | -61.84% | -41.34% | -36.13% | -27.89% |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | -142.06% | -89.80% | -79.42% | -61.57% |
| Cibus, Inc. (CBUS)vs › | $119.84M | -17.99% | -23.22% | -53.77% | -63.92% |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | -50.67% | -131.41% | -97.53% | -74.13% |
| Seer, Inc. (SEER)vs › | $120.41M | -28.87% | -28.06% | -25.36% | -20.47% |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | -1.78% | -41.34% | -32.26% | -28.21% |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | -19.83% | -23.34% | -19.01% | -18.39% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | -44.81% | -53.33% | -46.90% | -39.65% |
| BGM Group Ltd. (BGM)vs › | $122.43M | -3.19% | -2.23% | -1.75% | 1.24% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | -74.08% | -72.79% | -71.36% | -64.12% |
ROIC
-61.8%
ROE
-57.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -61.84% |
| 2026-03-31 | -47.96% |
| 2025-12-31 | -32.01% |
| 2025-09-30 | -34.93% |
| 2025-06-30 | -29.94% |
| 2025-03-31 | -30.86% |
| 2024-12-31 | -28.60% |
| 2024-09-30 | -31.61% |
| 2024-06-30 | -38.80% |
| 2024-03-31 | -38.25% |
| 2023-12-31 | -139.66% |
| 2023-09-30 | -75.09% |
| 2023-06-30 | -22.64% |
| 2023-03-31 | -24.99% |
| 2022-12-31 | -235.01% |
| 2022-09-30 | -30.02% |
| 2022-06-30 | -24.89% |
| 2022-03-31 | -20.74% |
| 2021-12-31 | -15.50% |
| 2021-09-30 | -12.16% |
| 2021-06-30 | -10.28% |
| 2021-03-31 | -12.89% |
